DE602006010329D1 - Verfahren zur herstellung eines indolon-derivats - Google Patents

Verfahren zur herstellung eines indolon-derivats

Info

Publication number
DE602006010329D1
DE602006010329D1 DE602006010329T DE602006010329T DE602006010329D1 DE 602006010329 D1 DE602006010329 D1 DE 602006010329D1 DE 602006010329 T DE602006010329 T DE 602006010329T DE 602006010329 T DE602006010329 T DE 602006010329T DE 602006010329 D1 DE602006010329 D1 DE 602006010329D1
Authority
DE
Germany
Prior art keywords
formula
group selected
atom
methylbenzylsulfonyloxy
butanesulfonyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010329T
Other languages
English (en)
Inventor
Rohit Ravikant Soni
Hitarth Harshendu Acharya
Hetal Rameshchandra Shah
Buchi Reguri Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alembic Ltd
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of DE602006010329D1 publication Critical patent/DE602006010329D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602006010329T 2005-02-15 2006-02-15 Verfahren zur herstellung eines indolon-derivats Active DE602006010329D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN77MU2005 2005-02-15
PCT/IN2006/000052 WO2006123356A1 (en) 2005-02-15 2006-02-15 Process for the preparation of indolone derivative

Publications (1)

Publication Number Publication Date
DE602006010329D1 true DE602006010329D1 (de) 2009-12-24

Family

ID=37027535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010329T Active DE602006010329D1 (de) 2005-02-15 2006-02-15 Verfahren zur herstellung eines indolon-derivats

Country Status (13)

Country Link
US (1) US7619095B2 (de)
EP (1) EP1848691B1 (de)
JP (1) JP2008530201A (de)
KR (1) KR20070112196A (de)
AT (1) ATE448201T1 (de)
AU (1) AU2006248578A1 (de)
BR (1) BRPI0608244A2 (de)
CA (1) CA2597791A1 (de)
DE (1) DE602006010329D1 (de)
ES (1) ES2336486T3 (de)
PL (1) PL1848691T3 (de)
WO (1) WO2006123356A1 (de)
ZA (1) ZA200707888B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008084499A1 (en) * 2007-01-10 2008-07-17 Ind-Swift Laboratories Limited An industrial process for the preparation of pure ropinirole
KR101059275B1 (ko) * 2008-12-23 2011-08-24 일동제약주식회사 개선된 4-[2-(디-엔-프로필아미노)에틸]-1,3-디하이드로-2에이치-인돌-2-온의 제조 방법
AU2009356855A1 (en) * 2009-12-16 2012-08-09 Pharmathen S.A. Process for the preparation of Ropinirole and salts thereof
CN101891641B (zh) * 2010-07-27 2015-06-10 北京华禧联合科技发展有限公司 盐酸罗匹尼罗关键中间体的稳定形态及其制备
CN102654045B (zh) * 2012-05-10 2015-07-08 中国石油天然气股份有限公司 顶部注空气重力辅助驱采油一维物理模拟实验系统
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754938A (en) * 1980-09-20 1982-04-01 Konishiroku Photo Ind Co Ltd Developing method for positive type photosensitive lithographic printing plate
CN100457711C (zh) * 2005-06-27 2009-02-04 上海奥博生物医药技术有限公司 2-甲基-3-硝基苯基烷基胺衍生物或其盐的制备方法

Also Published As

Publication number Publication date
CA2597791A1 (en) 2006-11-23
EP1848691A1 (de) 2007-10-31
US20080262244A1 (en) 2008-10-23
US7619095B2 (en) 2009-11-17
ATE448201T1 (de) 2009-11-15
JP2008530201A (ja) 2008-08-07
PL1848691T3 (pl) 2010-05-31
BRPI0608244A2 (pt) 2016-02-10
AU2006248578A1 (en) 2006-11-23
WO2006123356A1 (en) 2006-11-23
KR20070112196A (ko) 2007-11-22
WO2006123356B1 (en) 2007-01-18
ES2336486T3 (es) 2010-04-13
EP1848691B1 (de) 2009-11-11
ZA200707888B (en) 2009-01-28

Similar Documents

Publication Publication Date Title
DE602006010329D1 (de) Verfahren zur herstellung eines indolon-derivats
HRP20120173T1 (en) 1- ¦[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
RU2404982C2 (ru) Применение соединений пирролохинолина для уничтожения клинически латентных микроорганизмов
ATE518845T1 (de) Optische isomere eines iloperidon-metaboliten
RS52245B (en) CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES AND THEIR THErapeutic Use
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20062370L (no) Amidderivater
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20050429L (no) Substituert kinolin-CCR5-reseptorantagonister
NO20060774L (no) Kinolin- og kinazolinderivater som har affinitet for 5HT1-typereseptorer
MX2007012883A (es) Derivados de dihidrobenzofurano y usos de los mismos.
PE20130215A1 (es) Nuevos derivados de ciclohexilamina que tienen actividad como agonistas adrenergicos beta2 y como antagonistas muscarinicos m3
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
RS54608B1 (en) CGRP RECEPTOR ANTAGONITY
EA201000486A1 (ru) Ингибитор белка, активирующего 5-липоксигеназу (flap)
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MX2021008263A (es) Métodos de tratamiento de afecciones relacionadas con el receptor s1p1.
PE20070355A1 (es) Antagonistas de cgrp seleccionados y procedimientos para su preparacion
ATE396183T1 (de) Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
MX2022005615A (es) Derivado triciclico de dihidroimidazopirimidona, metodo de preparacion del mismo, composicion farmaceutica y uso del mismo.
DK1712225T3 (da) Substituered carbostyril-derivater som agonister af receptorundertype 5-HT 1A til behandling af bipolar lidelse
DK1246789T3 (da) Fremgangsmåde til fremstilling af optisk ren (R)- og (S)-didesmethylsibutramin
JP2005521705A5 (de)
NO20071319L (no) Fremgangsmate for fremstilling av isotiazolderivater.
ATE424820T1 (de) Verwendung von pyrrolederivaten gegen angstzustände

Legal Events

Date Code Title Description
8364 No opposition during term of opposition